FDA Inspection 728741 — LifeServe Blood Center

LifeServe Blood Center — FEI 1970344

The FDA completed an inspection of LifeServe Blood Center on June 7, 2011 in Sioux City, IA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 3 citations were issued during this inspection. Product area: Biologics.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
June 7, 2011
Fiscal Year
2011
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Sioux City, IA (United States)

Citations

IDCFRDescription
15421 CFR 606.160(a)(1)Concurrent documentation
441521 CFR 211.204Returned drug products with doubt cast as to safety et. al.
9121 CFR 606.100(b)(12)Criteria for suitability of reissue of returned blood